Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q2 EPS of ($0.75), $0.04 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.